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Germinal centers (GCs) were first described by 
histologists in 1884 and named as such because 
they were thought to be the site of lymphoid 
cell development. In the last century, we learned 
that GCs are actually sites of B cell clonal ex-
pansion and diversification (Berek et al., 1991; 
Jacob et al., 1991; MacLennan, 1994). These 
structures are formed during immune responses 
and remain for 20–100 d after immunization 
(Liu et al., 1991; Bachmann et al., 1996). Dur-
ing this period, they continually produce ex-
panded clones of memory B cells and plasma 
cells that are related by somatic hypermutation 
(Jacob et al., 1991; Liu et al., 1991).
After antigen capture, B cells migrate to the 
interface between the T and B cell zones in 
lymphoid organs, where they cluster with anti-
gen-specific T cells and DCs and begin divid-
ing  (Ansel  et  al.,  1999;  Okada  and  Cyster, 
2006; Coffey et al., 2009). Subsequently, one 
to five clones of dividing B cells migrate into 
the B cell follicle and form antigen-specific 
GCs, which also contain follicular DCs (FDCs), 
tingible body macrophages, specialized fol-
licular helper T cells, and conventional DCs 
(Kroese et al., 1987; Jacob et al., 1991; Liu et al., 
1991; Küppers et al., 1993). FDCs differentiate 
from existing mesenchymal cells in the B cell 
follicle and express receptors for immune com-
plexes, which facilitate the capture and pro-
longed display of antigen which is believed to 
contribute to the selection of B cells bearing 
mutated high-affinity receptors.
Once a GC is established in the B cell folli-
cle  it  develops  dark  and  light  zones,  which 
were traditionally thought to be the sites of 
clonal  expansion  and  selection,  respectively. 
However, intravital imaging revealed that GC 
B cells move between the light and dark zone 
compartments in a manner that makes this 
simple model improbable (Allen et al., 2007; 
Hauser et al., 2007; Schwickert et al., 2007; 
Figge et al., 2008). In addition, GCs were 
found to be open structures that include naive 
follicular B cells, which are frequent visitors to 
the light zones (Allen et al., 2007; Schwickert 
et al., 2007). These B cells, which do not ap-
pear  to  actively  participate  in  the  reaction, 
make contact with FDCs, suggesting that all 
such B cells may deliver antigen to GCs as well 
as scan for cognate antigen (Schwickert et al., 
2007; Suzuki et al., 2009). Consistent with the 
idea  that  GCs  remain  open,  B  cells  bearing 
high-affinity  receptors  specific  for  the  initial 
immunogen are recruited to an ongoing GC 
reaction, which suggests a mechanism whereby 
cognate antigen-specific B cells that were not 
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Germinal centers (GCs) are specialized structures in which B lymphocytes undergo clonal 
expansion, class switch recombination, somatic hypermutation, and affinity maturation. 
Although these structures were previously thought to contain a limited number of isolated 
B cell clones, recent in vivo imaging studies revealed that they are in fact dynamic and 
appear to be open to their environment. We demonstrate that B cells can colonize heter-
ologous GCs. Invasion of primary GCs after subsequent immunization is most efficient when 
T cell help is shared by the two immune responses; however, it also occurs when the im-
mune responses are entirely unrelated. We conclude that GCs are dynamic anatomical 
structures that can be reutilized by newly activated B cells during immune responses.
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after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
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mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
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nonical B cell immune responses dominated by specific anti-
hapten IgH VDJs (VH186.2/JH2 for NP and S107/JH1 for 
PC; Fig. S1 a). Genomic DNA isolated separately from three 
GC serial sections was used for gene amplification. Clonal ex-
pansion was demonstrated by the presence of related B cell 
clones in independent serial sections in the same GC (Fig. S1 a, 
bottom). In samples that were immunized and boosted with 
PC-KLH,  we  found  expanded  B  cell  clonal  families  with 
unique S107/JH1 V(D)Js in the lymph nodes of four immu-
nized mice. Expanded clones varied in size from 3–11 mem-
bers, which were related by somatic hypermutation (Fig. S1 b). 
The same GCs also contained occasional B cells bearing the 
VH186.2/JH2 heavy chain; however, these cells were not 
clonally expanded, suggesting that they might have been 
unique B cells in transit through the GC. In contrast, mice 
immunized with PC-KLH followed by NP-KLH showed ex-
panded clones of both B cells bearing unique S107/JH1 and 
VH186.2/JH2 recombination in the same GC (Fig. S1, b and c; 
and Fig. S2). We conclude that sequential administration of 
two antigens that share the same carrier leads to efficient inva-
sion of GCs by heterologous high-affinity B cells.
Studies in pathogen-free mice showed that GCs are rap-
idly induced by immunization and subsequently regress after 
3–14 wk (Jacob et al., 1991; Liu et al., 1991; Bachmann et al., 
1996). However, GCs appear to be constant features of sec-
ondary lymphoid tissues like human tonsils and Peyer’s patches, 
which are continually exposed to antigens. Our experiments 
reconcile these two apparently conflicting observations by 
demonstrating that GCs can be reutilized during immune 
responses to heterologous antigens.
In addition to obviating the requirement of reconstruct-
ing the GC environment, the observation that existing GCs 
can be used by newly activated B cells is consistent with, and 
may provide a physiological context for, the fact that B cells 
that are nonspecifically stimulated by transgenic expression of 
LMP2A can be found in GCs in Peyer’s patches (Casola   
et al., 2004). Accordingly, activated B cell entry into an on-
going GC may be a default option when the existing struc-
ture is available.
Kinetics of GC invasion
To further investigate B cell invasion of preexisting heterolo-
gous GCs, we examined the kinetics of this specific response. 
Allotype-marked Ars-specific B cells were transferred to B6-
CD45.1 recipients 1 d before immunization with Ars-KLH 
in alum. Mice were boosted with NP-KLH 8 d after the ini-
tial immunization and received NP-specific B cells after one 
additional day (Fig. 2 a).
1 d after the NP-specific B cell transfer, when Ars-specific 
GCs were already established, the NP-specific B cells were dis-
tributed throughout the B cell follicle (Fig. 2 b, left). As early as 
2 d after NP-specific B cell transfer, these cells were concen-
trated at the T-B interface. By day 4, they completely populated 
Ars-specific GCs (Fig. 2 b, middle and right, respectively).
B cells are activated by surface immunoglobulin cross-
linking by soluble antigen or deposits of immune complexes 
initially involved could also join in an ongoing immune re-
sponse (Schwickert et al., 2007). However, the possibility 
that GCs might also be co-opted during immune responses to 
unrelated antigens was not examined.
In this paper, we show that preexisting GCs are reutilized 
during heterologous immune responses. Sequential immuniza-
tion with two different haptens produced GCs with mixed 
hapten-specific B cell populations, which demonstrates the plas-
ticity of the GC microenvironment. We conclude that GCs are 
not limited to one time use. On the contrary, they are open to 
reutilization during immune responses to unrelated antigens.
RESULTS AND DISCUSSION
B cells use preexisting GCs
To examine the relationship between B cells that respond to 
two different antigens in vivo, we initially made use of previ-
ously characterized mice that carry targeted Ig genes specific 
for either 4-hydroxy-3-nitrophenol (NP) or arsonate (Ars; 
Liu et al., 2007; Shih et al., 2002). Mutant mice carrying the 
NP  (B1-8hi)-  or  Ars  (HKI65/Vk10)-specific  B  cells  were 
maintained on a B6-CD45.2 background. Those with the 
NP-specific antigen receptors also carried a transgene encod-
ing GFP (Schaefer et al., 2001) to facilitate cell tracking in 
B6-CD45.1 hosts (Fig. 1 a).
In adoptive transfer experiments, 8 d after immunization 
with Ars–keyhole limpet hemocyanin (KLH) in alum, large 
GCs containing B cells specific for Ars were present (Fig. 1 a, 
right). To determine whether heterologous B cells would en-
ter and participate in an ongoing GC reaction, mice with 
Ars-specific  GCs  received  NP-specific  B  cells  and  were 
boosted with NP-KLH (Fig. 1 a). 6 d after the boost, the 
composition of the GCs was assessed by immunohistology 
(Fig. 1 b). In theory, this protocol could have produced three 
outcomes: GCs containing either Ars- or NP-specific B cells, 
or a mixture of both (Fig. 1 c). Most (73%) GCs contained 
both NP- and Ars-specific B cells (60 out of 82 GCs; Fig. 1, 
b [right] and c). Only 24% of the GCs were NP restricted, 
and these may have contained endogenous KLH-specific 
B cells which were not visualized (20 out of 82 GCs; Fig. 1 c). 
A very high efficiency of invasion of preexisting GCs is dem-
onstrated by the fact that only a minor fraction (2%) of all 
GCs is Ars-restricted (2 out of 82 GCs; Fig. 1 c). In contrast, 
control mice that received the heterologous B cell transfer 
but  were  primed  and  boosted  with  either  Ars-KLH  or 
NP-KLH exhibited GCs containing only Ars- or NP-specific 
B cells, respectively (49 out of 49 GCs or 33 out of 33 GCs, 
respectively; Fig. 1, b [middle and left] and c).
The experiments reported in the previous paragraphs were 
performed with B cells carrying knockin antigen receptors. 
To determine whether B cells invade GCs specific for heter-
ologous antigens under physiological conditions, an experi-
ment was performed in which we immunized and boosted 
wild-type mice and examined GC B cells by laser microdis-
section  and  DNA  sequencing.  C57BL/6  mice  immunized 
with  phosphorylcholine  (PC;  Rudikoff  and  Potter,  1980; 
Ruppert et al., 1980) or NP (Reth et al., 1978) develop ca-JEM VOL. 206, December 21, 2009  2909
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Figure 1.  B cell invasion of established GCs. (a) Time line of immunization and B cell transfer. Ars-specific B cells (B6-CD45.2 HKI65/Vk10) were 
transferred 1 d before primary immunization (day 10) and NP-specific B cells (B6-CD45.2/GFP B1-8hi) were transferred 1 d before boosting (day 1) 
into wild-type (B6-CD45.1) mice. Ars-specific GCs were detected in histological sections, 9 d after priming (day 0; right: B6-CD45.2/GFP B1-8hi [green and 
red], B6-CD45.2 HKI65/Vk10 [red], IgD [blue]). (b) Representative histological sections of lymph nodes harvested 6 d after NP-KLH boost. Both transferred 
B cell populations (HKI65/Vk10 and B1-8hi) are membrane stained by CD45.2 (red), whereas B1-8hi B cells are additionally GFP+ (green; B1-8hi appear yel-
low because of GFP/CD45.2 double staining). To visualize GCs within secondary follicles, mantle zone B cells were stained by IgD (blue, top) or FDCs were 
stained by CD35 (blue, bottom). The top row shows whole cross sections of popliteal lymph nodes, and the bottom row shows more magnified views of 
GCs. Priming and boosting antigens are indicated at the top. Bars, 200 µm. (c) Statistical analysis of data shown in b. GCs were categorized in three 
groups: GCs with only NP-specific B cells, with both NP- and Ars-specific B cells, or with only Ars-specific B cells. Each data point represents the percent-
age of GCs in one of the categories for each mouse. Error bars show the standard deviation. Two independent experiments were performed with a total of 
four mice (two mice per control).2910 Germinal center reutilization | Schwickert et al.
Fig. S3, c [bottom left] and d). Adding the adjuvant alum to 
the boost resulted in an increased invasion of GCs in both 
cases (21 out of 21 GCs; Fig. S3, c [bottom right] and d; and 
36 out of 38 GCs; Fig. S4, a and b).
In contrast, at the same time point, there was no GC B 
cell formation and little invasion in the absence of preexisting 
T cell help. Immunization with Ars-KLH followed by injec-
tion with NP-CGG only produced a few mixed Ars- and 
NP-specific GCs (2 out of 98 GCs; Fig. 3, b [top] and c), 
whereas the rest was Ars specific. Similarly, when the double 
hapten-conjugated NP,Ars-CGG was used in the boost after 
priming with Ars-KLH (Fig. S3 a), NP-specific B cells were 
not found in GCs (0 out of 17 GCs; Fig. S3, c [top left] and d). 
Therefore, antibodies against a common epitope cannot be 
responsible for the effect. However, adding alum to the boost 
with NP-CGG or NP,Ars-CGG produced mixed GCs in 
both cases (6 out of 21 GCs; Fig. S3, c [top right] and d; and 
34 out of 76; Fig. S4, a and b). Therefore, T cell help is re-
quired for B cells to join ongoing GCs.
We found delayed kinetics but highly efficient GC inva-
sion when the protein carrier was switched but an adjuvant 
was provided in the boost. When mice were primed with 
Ars-KLH in alum and boosted with NP-OVA–containing 
LPS (Fig. 4 a), NP-specific B cells only appeared in heterolo-
gous Ars-specific GCs on day 6 (Fig. 4, b [bottom right] and c). 
All of the NP-specific GCs were mixed and also contained 
Ars-specific B cells (Fig. 4 c). In contrast, NP-specific B cells 
were already present in GCs in large numbers by day 4 when 
the carrier was shared (Fig. 4, b [top left] and c).
on FDCs and subcapsulary sinus macrophages (Carrasco and 
Batista, 2007; Junt et al., 2007; Phan et al., 2007; Roozendaal 
et al., 2009). Once activated, B cells express CCR7, a che-
mokine receptor which facilitates the cells’ migration to the 
interface between the T cell zone and the B cell follicle (Ansel 
et al., 1999; Okada et al., 2005). After receiving cognate T 
cell help, B cells begin to proliferate and retreat back into 
the B cell follicle, where they form GCs (Berek et al., 1991; 
Jacob et al., 1991; MacLennan, 1994; Rajewsky, 1996). Our 
experiments show that in the presence of an ongoing GC re-
sponse, the initial response to a novel antigen proceeds by the 
canonical route of GC B cell development (i.e., by migration 
to the T/B interface) before reentering the B cell follicle. 
However, once the B cell has started to proliferate, it can 
choose to either initiate a new GC or join an existing GC 
that was formed in response to a heterologous antigen.
T cell help and GC reutilization
To determine whether GC B cell invasion is dependent on 
shared T cell help, we compared immunization with either 
Ars–chicken gamma globulin (CGG) or Ars-KLH in alum, 
followed by a boost with NP-CGG (lipopolysacharide free; 
Fig. 3 a). We found that when the same protein carrier was 
used for both immunization and boost, NP-specific B cells 
were found in the majority of all GCs (44 out of 61 GCs; Fig. 3, 
b [bottom] and c). The same results were observed when the 
double hapten conjugate NP,Ars-CGG was used in the boost 
after priming with Ars-CGG (Fig. S3, a–d); NP-specific   
B cells were found in almost every GC (12 out of 13 GCs; 
Figure 2.  Kinetics of GC invasion. (a) Time line of immunization and B cell transfer. Ars-specific B cells (B6-CD45.2 HKI65/Vk10) were transferred into 
wild-type (B6-CD45.1) mice. 11 d later (day 0), NP-specific B cells (B6-CD45.2/GFP B1-8hi) were transferred. Mice were immunized with Ars-KLH in alum 
24 h after Ars-specific cells were transferred. 1 d before the transfer of NP-specific B cells, mice were boosted with NP-KLH. (b) Histological sections of 
lymph nodes harvested at 1, 2, and 4 d after NP-KLH boost stained with CD45.2 (red) and IgD (blue) to label all transferred B cells (HKI65/Vk10 and B1-8hi) 
and naive B cells, respectively. Transferred NP-specific B1-8hi B cells were additionally GFP+ (green). Representative images of secondary follicles from two 
independent experiments are displayed. The dashed line indicates the T/B cell interface. Bars, 200 µm.JEM VOL. 206, December 21, 2009  2911
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In contrast, this mechanism might, in part, facilitate the 
diversification of autoantibody responses during the course of 
autoimmune diseases, a phenomenon referred to as epitope 
spreading (Deshmukh et al., 2005). For example, in systemic 
lupus erythematosus, the first autoantibodies to be detected 
are frequently specific for SmD (Smith D). However, in later 
stages of the disease, affected individuals typically develop 
antibodies to A–ribonuclear protein (RNP) and/or SmB 
(Deshmukh et al., 2002). SmD, A-RNP and SmB are all part 
of the U1–small nuclear (sn) RNP complex; therefore, anti–
A-RNP or –SmB-specific B cells would share cognate T 
cell help with anti-SmD B cells. Also, any GC-containing 
We conclude that in the presence of T cell help, B cells 
rapidly enter preexisting GCs containing B cells that are spe-
cific for heterologous antigens. In the absence of shared T 
cell help, B cell invasion of established GCs still occurs; how-
ever, it occurs with delayed kinetics that are consistent with 
de novo development of helper T cells.
B  cells’  ability  to  join  preexisting  heterologous  GCs 
would be an advantage in any infection that involves the de-
velopment of variant pathogens, such as HIV, or parasites 
with variant coat proteins. In these types of infections, B cells 
specific for a nascent variant might be able to rapidly join a 
GC that already contained shared T cell help.
Figure 3.  Invasion of heterogeneous GCs in the presence and absence of preexisting T cell help. (a) Time line of immunization and B cell trans-
fer. Ars-specific B cells (B6-CD45.2 HKI65/Vk10) were transferred 1 d before primary immunization (day 10) and NP-specific B cells (B6-CD45.2/GFP B1-
8hi) were transferred 1 d before boosting (day 1) into wild-type (B6-CD45.1) mice. Mice were immunized with either Ars-KLH or Ars-CGG in alum. All 
mice were boosted with NP-CGG. (b) Representative histological sections of secondary follicles of lymph nodes harvested 6 d after NP-CGG boost stained 
with CD45.2 (red) and IgD (blue) to label all transferred B cells (HKI65/Vk10 and B1-8hi) and naive B cells, respectively. Transferred NP-specific B1-8hi B 
cells were additionally GFP+ (green). Antigens used for priming and boosting are indicated on the right. The top and bottom show data obtained from 
mice that were primed with Ars-KLH and Ars-CGG, respectively. All mice were boosted with NP-CGG. Bars, 100 µm. (c) Statistical analysis of data repre-
sentatively shown in b. GCs were categorized into B1-8hi positive and negative. Symbols represent the percentage of GCs containing B1-8hi transferred B 
cells for each individual mouse. Error bars show the standard deviation. Two experiments were performed with a total of six mice per condition.2912 Germinal center reutilization | Schwickert et al.
Figure 4.  Delayed invasion in the absence of preexisting T cell help in GCs. (a) Time line of immunization and B cell transfer. Ars-specific B cells 
(B6-CD45.2 HKI65/Vk10) were transferred into wild-type (B6-CD45.1) mice. 11 d later (day 0), NP-specific B cells (B6-CD45.2/GFP B1-8hi) were transferred. 
Mice were immunized with Ars-KLH in alum 1 d after Ars-specific cells were transferred. 1 d before the transfer of NP-specific B cells, mice were boosted 
with either NP-KLH or NP-OVA. (b) Histological sections of lymph nodes harvested 4 d (left four) and 6 d (right four) after NP-KLH (top) or NP-OVA (bot-
tom) boost. Sections were stained with CD45.2 (red) and IgD (blue) to label all transferred B cells (HKI65/Vk10 and B1-8hi) and naive B cells, respectively. 
Transferred NP-specific B1-8hi B cells were additionally GFP+ (green). Bars, 200 µm. (c) Statistical analysis of data represented in b. GCs were categorized 
into the same three groups as described in Fig 1 c. Symbols indicate the percentage of GCs in one of the categories for each individual mouse. Error bars 
show the standard deviation. Two independent experiments were performed with a total of three or two mice.JEM VOL. 206, December 21, 2009  2913
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SmD-reactive B cells would also contain anti–U1-snRNP-
specific T cells and could be joined by activated anti–A-RNP 
or –SmB B cells during the course of the disease.
Two-photon  imaging  revealed  that  GCs  are  dynamic 
open structures. Naive B cells continually transit through the 
GC  light  zone,  where  they  interact  with  antigen-bearing 
FDCs (Schwickert et al., 2007). If a B cell carries antigen in 
the form of immune complexes bound to complement re-
ceptors, the latter may be deposited on FDCs (Phan et al., 
2007). Alternatively, if the naive cell is specific for the anti-
gens displayed by the FDC, the interaction of the two cell 
types might lead to B cell activation and, ultimately, to GC 
invasion (Schwickert et al., 2007). These dynamic features 
are consistent with the observation that GCs contain multiple 
clones of unrelated cells, as well as naive B cells, and that the 
same clone of B cells can be found in more than one GC 
(Küppers et al., 1993; Bende et al., 2007). Together with 
these observations, our experiments suggest a new model for 
the GC, one which is open to naive B cell transit as well as to 
colonization by B cells responding to heterologous antigens.
MATERIALS AND METHODS
Mice. C57BL/6 (B6-CD45.2), B6-CD45.1, and B6-GFP (Schaefer et al., 
2001) mice were purchased from The Jackson Laboratory. B1-8hi (Shih et al., 
2002) and HKI65/Vk10 (Heltemes-Harris et al., 2004; Liu et al., 2007) IgH 
knockin mice were maintained at the Rockefeller University and the Thomas 
Jefferson University. For adoptive transfer experiments, donor mice were 8–16 
and recipients were 6–10 wk old. Mice were housed under specific pathogen-
free conditions. All animal protocols were approved by the Rockefeller and 
the Thomas Jefferson University Animal Care and Use Committees.
Immunization. Mice were primed with 25–40 µg antigen precipitated in 
alum (2:1) injected s.c. into their hind footpads and into the base of the tail. 
9–10 d later, they were boosted by injection with 50–80 µg of soluble or alum-
precipitated antigen s.c. in their hind footpads and into the base of the tail.
Adoptive B cell transfer. B cells were purified by immunomagnetic de-
pletion with anti–CD43-beads (Miltenyi Biotec). NP-specific B cells were 
further enriched by depletion of Ig+ cells (anti–Ig-PE [BD] and anti-PE 
beads [Miltenyi Biotec]). 2–3 × 106 HKI65/Vk10 and B1-8hi Ig+ B cells 
were transferred i.v. 1 d before or after the antigen boost.
Immunofluorescence. Cryostat sections of lymph nodes were fixed and 
stained as described previously (Lindquist et al., 2004). In brief, organs were 
fixed in PBS with 4% paraformaldehyde plus 10% sucrose and cryoprotected 
in PBS plus 30% sucrose before being embedded in optimum cutting tempera-
ture compound (OCT) and frozen. Frozen lymph nodes and spleens were 
sectioned (20 µm thickness) on a microtome and fixed in acetone. For immuno-
staining, all incubations were performed in a humidified chamber at room 
temperature. Sections were blocked in 5% BSA, 10% mouse serum, and sequen-
tially with excess streptavidin and biotin (Vector Laboratories). The following 
antibodies were used for staining: anti–IgD-Alexa Fluor 647 (1:200; eBiosci-
ence),  anti–IgD-FITC  (1:100;  eBioscience),  anti–CD45.2-PE  (1:250; 
eBioscience), PNA-biotin (1:1,000; Vector Laboratories), CD35-bio (1:500; 
eBioscience), and SA-Cy3 (1:500; Jackson ImmunoResearch Laboratories).
Laser microdissection. Lymph nodes were embedded in OCT, frozen, 
sectioned (20 µm thickness) on a microtome, and collected on membrane 
slides (Molecular Machines & Industries). Sections were fixed with 75% 
Ethanol for 30 s, washed with PBS for 2 min, incubated with anti–IgD-
FITC in PBS for 5 min at 4°C, washed twice with PBS for 1 min, and de-
hydrated by incubating for 30 s in 75% ethanol followed by 95% ethanol. 
GCs (IgD regions in B cell follicles) were laser dissected on a Cellcut system 
(Molecular Machines & Industries) fitted with a 355-nm solid-state laser at 
the Rockefeller Bio-imaging facility and collected in nuclease-free tubes 
with adhesive lids (Molecular Machines & Industries). Biopsies from the 
same GCs but from serial lymph node sections were collected and processed 
separately. The QIAamp DNA micro kit (QIAGEN) was used to isolate ge-
nomic DNA.
PCR and sequence analysis. Nested PCR was used to amplify VH186.2-
JH2 and S107-JH1 genes from GC B cells. NP-specific VH186.2-JH2 clones 
were amplified using the outer primers FO_58_VH186.2 (5-CATGGGATG-
GAGCTGTATCATGC-3) and RO_55.9_JH2 (5-CTCACAAGAGTCC-
GATAGACCCTG-3) and 25 cycles at 94°C for 30 s, 55.5°C for 30 s, and 
72°C for 90 s, followed by the inner primers FI_55.7_VH186.2 (5-GGT-
GACAATGACATCCACTTTGC-3)  and  RI_56_JH2  (5-GACTGT-
GAGAGTGGTGCCTTG-3) and 25 cycles at 94°C for 30 s, 55.5°C for 30 s, 
and 72°C for 90 s. PC-specific S107-JH1 clones were amplified using the outer 
primers  FO_58.8_S107  (5-CCTGAGTTCCCCAATCTTCACATTC-3) 
and RO_59.1_JH1 (5-AGCCTCTGACTGCCTCTTTTCCTG-3) and 25 
cycles at 94°C for 30 s, 57°C for 30 s, and 72°C for 90 s, followed by the inner 
primers FI_56.6_S107 (5-CAGGTATCCAGTGTGAGGTGAAGC-3) and 
RI_58.2_JH1 (5-CGTTTCAGAATGGAATGTGCAGA-3) and 25 cycles 
at 94°C for 30 s, 55.5°C for 30 s, and 72°C for 90 s. PCR was performed with 
DNA from 25 GCs per condition and at least three serial biopsies per GC. All 
amplified products were cloned (Topo Cloning kit; Invitrogen), sequenced, 
and analyzed using MegAlign (DNASTAR). Unique sequences from indi-
vidual GCs were analyzed for mutated clones and existence of the same clone 
in multiple serial sections. HotStarTaq (QIAGEN) DNA polymerase with an 
error rate of 2 × 105/nucleotide and cycle was preferred over high-fidelity 
enzymes with a 10× lower error rate because of its high amplification effi-
ciency. The mutation frequency was 102. The mutation frequency for PC-
specific sequences was 0.8 × 102 or 1.1 × 102 for mice that were boosted 
with PC-KLH or NP-KLH, respectively, and for NP-specific sequences was 
1.2 × 102 or 1.1 × 102 for mice that were boosted with PC-KLH or NP-
KLH, respectively.
Confocal microscopy. Confocal images were acquired on an LSM 510 sys-
tem (Carl Zeiss, Inc.) with a 488-, 543-, and 633-nm excitation line at the 
Rockefeller Bio-Imaging Facility. Z-stack (2–4 planes, 3-µm z-steps) images 
were obtained with a C-Apochromat 40× (NA 1.2, W corr), a Plan Apochro-
mat 20× (NA 0.75), and a Plan Neofluar 10× (NA 0.3) objective. An array of 
25 or 40× images was taken with a motorized stage to capture the entire cut 
surface of the lymph node.
Analysis of GC composition in histological sections. GCs, defined by 
PNA+, CD35+, or IgD staining in B cell follicles, were categorized according 
to their composition. GCs enriched in both transferred Ars- and NP-specific B 
cell populations were classified as mixed. GCs were only scored as positive for 
the transferred B cell type if we found a higher density and IgD of transferred 
cells in the GC than in the B cell follicle.
Online supplemental material. Fig. S1 and Fig. S2 show the invasion of 
preexisting GCs in wild-type mice by laser microdissection and BCR sequence 
analysis. Fig. S3 demonstrates that invasion of heterogeneous GCs in the pres-
ence of antigen-specific antibodies is depended on the availability of T cell 
help. Fig. S4 shows that invasion of heterogeneous GCs depends on the activa-
tion of antigen-specific T cell help. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20091225/DC1.
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